According to our new research report “US Stem Cell Market Analysis”, the US stem cell market has been witnessing an uptrend for the past few years on account of heavy private sector spending, large number of transplantations. Consequently, the US stem cell market is anticipated to grow at a CAGR of around 69% during 2010-2012.
Our in-depth analysis of the market has suggested that government support is the major factor for such a stupendous growth in the country’s stem cell market. The US government has lifted ban from stem cell funding in the early 2009, leading to high investments in the stem cell market. Hence, the R&D expenditure by the public and private sectors has surged in order to boost the stem cell banking in the country. In addition, several other initiatives including increased government monitoring of the market has been discussed in the report.
Our team of industry experts have segmented the US stem cell market on the basis of technology and product. The report has identified several emerging areas such as spinal cord injury, myocardial infarction and others. Detailed information of these therapeutic applications has also been provided in the report.
“US Stem Cell Market Analysis” also provides information of the key competitors in the market along with their business information and areas of expertise. The report shows a highly concentrated structure of the market, with top players dominating the market. It provides segment level analysis of the industry along with emerging trends that may shape up with the betterment of economic conditions.
The research will help consultants, industry analysts and vendors to get an in-depth knowledge of the current, past and future performance of the industry. The report provides an extensive research on the recent trends of the US stem cell market along with impartial analysis considering the impact of financial crisis on its performance.
For more information visit: http://www.rncos.com/Report/IM191.htm |
